IVF耗材胚胎毒性测试:制造商如何检测?
STUDY QUESTION: How do manufacturers perform embryotoxicity testing in their quality control programs when validating IVF consumables? SUMMARY ANSWER: The Mouse Embryo Assay (MEA) and Human Sperm Survival Assay (HSSA) used for IVF disposables differed from one manufacturer to ano…
要点
- IVF耗材制造商胚胎毒性测试方法差异大,MEA与HSSA阈值不一致。
- 部分测试参数可能影响胚胎毒性检测的敏感性。
核心结论
- 制造商对IVF一次性耗材的胚胎毒性测试高度异质,目前无相关法规。
研究设计与样本
- 聚焦胚胎移植导管、授精导管、吸管、血清移液管、培养皿和穿刺针。
- 登记小鼠品系、胚胎数、培养条件、提取方案、外包与阈值等参数并比较。
主要发现
- 各厂商MEA与HSSA的方法学和阈值存在显著差异。
- 部分参数可能影响测试的敏感性。
临床怎么用
- 专业人员应呼吁并要求供应公司对胚胎毒性测试进行标准化并提高透明度。
- 应敦促公司向用户提供清晰准确的测试结果及测试方法信息。
- 亟需未来建议以提高胚胎毒性实验的敏感性和可重复性。
局限性
- 虽联系主要IVF制造商,但问卷回复率相对较低。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: How do manufacturers perform embryotoxicity testing in their quality control programs when validating IVF consumables? SUMMARY ANSWER: The Mouse Embryo Assay (MEA) and Human Sperm Survival Assay (HSSA) used for IVF disposables differed from one manufacturer to another. WHAT IS KNOWN ALREADY: Many components used in IVF laboratories, such as culture media and disposable consumables, may negatively impact human embryonic development. STUDY DESIGN, SIZE, DURATION: Through a questionnaire-based survey, the main manufacturers of IVF disposable devices were contacted during the period November to December 2018 to compare the methodology of the MEA and HSSA. We focused on catheters for embryo transfer, catheters for insemination, straws, serological pipettes, culture dishes and puncture needles used in the ART procedures. PARTICIPANTS/MATERIALS, SETTING, METHODS: We approached the manufacturers of IVF disposables and asked for details about methodology of the MEA and HSSA performed for toxicity testing of their IVF disposable devices. All specific parameters like mouse strains, number of embryos used, culture conditions (media, temperature, atmosphere), extraction protocol, subcontracting, and thresholds were registered and compared between companies. MAIN RESULTS AND THE ROLE OF CHANCE: Twenty-one companies were approached, of which only 11 answered the questionnaire. Significant differences existed in the methodologies and thresholds of the MEA and HSSA used for toxicity testing of IVF disposables. Importantly, some of these parameters could influence the sensitivity of the tests. LIMITATIONS, REASONS FOR CAUTION: Although we approached the main IVF manufacturers, the response rate was relatively low. WIDER IMPLICATIONS OF THE FINDINGS: Our study confirms the high degree of heterogeneity of the embryotoxicity tests performed by manufacturers when validating their IVF disposable devices. Currently, no regulations exist on this issue. Professionals should call for and request standardization and a future higher degree of transparency as regards embryotoxicity testing from supplying companies; moreover, companies should be urged to provide the users clear and precise information about the results of their tests and how testing was performed. Future recommendations are urgently awaited to improve the sensitivity and reproducibility of embryotoxicity assays over time. STUDY FUNDING/COMPETING INTEREST(S): This study did not receive any funding. L.D. declares a competing interest with Patrick Choay SAS. TRIAL REGISTRATION NUMBER: N/A.
引用
- Delaroche L, Oger P, Genauzeau E, et al. Embryotoxicity testing of IVF disposables: how do manufacturers test? Hum Reprod. 2020. PMID: 32053198. doi:10.1093/humrep/dez277
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。